|
||||||||||||||||
|
||||||||||||||||
The following HTML text is provided to enhance online readability. Many aspects of typography translate only awkwardly to HTML. Please use the page image as the authoritative form to ensure accuracy. Ann Wion, J.D. Associate Chief Counsel for Drugs and Biologics U.S. Food & Drug Administration Bethesda, MD WORKING GROUP PARTICIPANTS June 21–23, 1992Frank Cano, Ph.D.2 Vice-President Lederle-Praxis Biologicals Pearl River, NY Mary Lou Clements, M.D. Professor and Head Division of Vaccine Sciences Johns Hopkins School of Hygiene and Public Health Baltimore, MD George Curlin, M.D. Deputy Director Division of Microbiology and Infectious Diseases National Institute for Allergy and Infectious Diseases Bethesda, MD Ciro de Quadros, M.D. Regional Advisor Expanded Program on Immunization Pan American Health Organization Washington, DC Michael Epstein, J.D. Partner Weil, Gotshal & Manges New York, NY Elaine Esber, M.D. Associate Director Center for Biologics Evaluation and Research U.S. Food & Drug Administration Bethesda, MD Ronald W. Hansen, Ph.D. Associate Dean for Academic Affairs William E. Simon Graduate School of Business University of Rochester Rochester, NY Kerri-Ann Jones, Ph.D. Chief, Human Resources Development, Energy and Private Sector U.S. Agency for International Development Washington, DC David T. Karzon, M.D. Professor Vanderbilt University
|
|
|||||||||||||||
